8 June 2021 - Deborah Wilkes
Premium
Reckitt is divesting its Infant Formula and Child Nutrition (IFCN) business in China to private-equity firm Primavera Capital Group in a transaction valuing the business at USD2.2 billion.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.